Financials
Financial year 2025
INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS from Lasne, company number BE0476647607, closed financial year 2025 with a result of € 388,253 after tax. For that financial year INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS recorded a gross margin of € -61,403 and equity of € 140,244. Compared with financial year 2024, the result moved from € -16,515 to € 388,253. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 140,244
▲ € 388,253 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 388,253
▲ still € 16,515 loss in 2024
Profit after tax over the fiscal year.
€ 246,805
▲ € 241,329 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 134,044.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 304
▼ 95% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 24,442
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -50,794 | € -53,862 | € 4,318 | € -61,403 | ▼ € 65,722 |
| Profit after taxes | € -143,013 | € 88,787 | € -16,515 | € 388,253 | ▲ € 404,768 |
| Equity | € -320,281 | € -231,493 | € -248,009 | € 140,244 | ▲ € 388,253 |
| Total debts | € 352,462 | € 292,491 | € 223,709 | € 139,433 | ▼ 38% |
| Cash | € 22,665 | € 26,225 | € 5,476 | € 246,805 | ▲ € 241,329 |
| Retained profit | € -326,481 | € -237,693 | € -254,209 | € 134,044 | ▲ € 388,253 |
| Balance sheet total | € 447,393 | € 458,415 | € 355,323 | € 279,677 | ▼ 21% |
Key figures of INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS?
What happened at INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 388,253. filed late Source: NBB ↗
- New establishment in Lasne. KBO
- Arnaud Pêtre became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 143,013 loss in 2022 to € 388,253 profit in 2025.
Paid € 36,156 in corporate taxes since 2022.
Best year ever: 2025, with € 388,253 profit.
A new publication or filing at INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS? We notify you, reason included.
Follow INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS is Arnaud Pêtre. Arnaud Pêtre is also behind NUDGE TO SAIL and BRAIN IMPACT NEUROSCIENCE.
Directors
According to the 2025 annual accounts
since 2002
Establishments
Establishment units
Physical locations of this company
Chemin du Bois Magonette 3
1380 Lasne
Chemin du Bois Magonette 2
1380 Lasne
Active since 8 March 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0476.647.607
- VAT number
- BE 0476.647.607
- Registered office
- Chemin du Bois Magonette 3, 1380 Lasne
- Names & denominations
- INTERNATIONAL CONSULTANT, VACCINES & BIOLOGICALS · I.C.V.B.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 February 2002
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.